Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
NF1 germline pathogenic variants cause the tumor predisposition syndrome neurofibromatosis type 1.
NF1 somatic alterations are present in 5% of all human sporadic cancers.
However, to date, the therapeutic impact of NF1 somatic alterations is poorly investigated.
…